We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Balanced Reporting. Trusted Insights.
Thursday, April 03, 2025
The Center for Food Safety, Beyond Pesticides and several farmworker advocacy groups are pushing the EPA to cancel glyphosate's registration in light of a federal court decision that found fault with the agency's human health assessment.
Bayer is sticking to its legal strategy of trying individual Roundup cases in court, even as a series of recent losses has some investors and plaintiffs’ lawyers questioning the wisdom of that approach.
Biotech plant developers are pleased with a proposal from the Animal and Plant Health Inspection Service to create five new regulatory exemptions for genetically modified plants.
Glyphosate will be renewed for another 10 years in the European Union after member states could not reach the required majority to reauthorize use of the chemical, the active ingredient in Roundup.
Corteva and Syngenta, two major seed and crop protection companies, reported lower overall sales for their third quarters but higher sales of seeds, as they look to navigate what one of their CEOs called “complicating geopolitical, macroeconomic and ag-specific factors.”
Bayer says it’s looking to restructure its business and trim management after reporting poor financial results for the latest quarter, largely driven by the performance of its Crop Science Division.
A label required by the state of California warning of glyphosate’s potential as a human carcinogen is unconstitutional, the 9th Circuit Court of Appeals concluded in a decision that could aid Bayer in its ongoing legal battle over Roundup.
Bayer said it will appeal a jury verdict from a local court in Philadelphia awarding $175 million, including $150 million in punitive damages,to an 83-year-old city resident who claimed exposure to Roundup caused his cancer.
